SUMMARY Tests of hepatic function do not correlate highly and this, together with their skew distribution, makes the information provided by them difficult to interpret. By means of an appropriate transformation it is possible to normalise their distributions so that the information from them can be combined in the form of a discriminant function which is not only easy to interpret but gives an index of severity of disease which is more reliable than any one single test. In this study nine tests were examined, and after normalisation it was found that only four tests were required to present almost all the information available in the nine. A formula is given for calculating the index in T-score form, which is particularly easy to interpret.
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A discriminant function of the type described retains the maximum information with the minimum number of biochemical tests. It therefore contributes to the solution of a problem which is causing increasing concern-the exponential increase in the number of investigations which the hospital services will soon find it impossible to bear.
Tests of hepatic function are used for determining the presence of damage to the liver, qualitatively in the differentiation between normal and disease and quantitatively for the measurement of improvement or deterioration. These purposes are by no means the same. For example, the presence of diseasemight give rise to the appearance of an abnormal metabolite and this would be of diagnostic value; but if the metabolite were not related quantitatively to the severity of disease it could not be used for the measurement of improvement or deterioration. In statistical terms, a test which is used to differentiate normal from disease should show a large significant difference between means of the two conditions, that is, have a small overlap of the distributions, but a test which is selected to measure deterioration or improvement should correlate highly with changes in function. Most tests of hepatic function measure the changes in concentration of metabolites which are normally present. They therefore measure severity of disturbance of function and can be used to detect disease only when the amount of change is such that the probability of such results being obtained from normal livers is sufficiently low.
It is well known from clinical experience that when a battery of tests of hepatic function is used the amount of change shown by them will differ considerably, depending upon the underlying pathology Received for publication 13 October 1976 and disturbance of function. The lack of correspondence between test results can be easily demonstrated by examining the correlations between them (Miloszewski et al., 1970) . Table 1 (Fig. 1) . When a frequency distribution of Gaussian form is plotted in the usual way it produces the familiar bell-shaped curve. When the distribution is plotted as a cumulative distribution, that is, the height of the curve for any one score represents the total frequency of cases up to that score, the curve has a stretched-out S shape. When this curve is plotted on probability paper it becomes a straight line (Hamilton, 1974) . In Fig. 1 the curve is drawn for alanine amino-transferase, and it is clear that then the data are converted into their logarithmic equivalents; the curve of the cumulative frequency distribution is effectively straightened out. Clinical experience has shown that, both for establishing the presence of disease and for assessing progress, reliance cannot be placed on one single Table 2 , is a measure of the efficiency with which the test distinguishes between the two groups. It can be seen that this varies considerably from the highest figure of 0 53 for alkaline phosphatase to the lowest of 0-14 for prothrombin time. The best combination (weighted sums) of the tests is found by calculating the multiple regression of the nine tests on the criterion. The nine weights so obtained are used to multiply the corresponding scores of each individual on the nine tests and the products are summed. This gives an index number which, when correlated with the criterion variable, gives a correlation of almost 0 70, which is obviously higher than the best individual test. The weights are given, in the last column of Table 2 , in standardised form which indicates clearly the relative importance of the tests in contributing to the total. Some of the weights are very small, which indicates that those tests are making a negligible contribution to the index number and could therefore be omitted without making any real difference.
The deletion of 'non-contributory' tests is done systematically with a computer program 'Multiple correlation by stepwise accretion and deletion' from the PLUS System (Hamilton, 1965) . This program deletes the test with the lowest weight and recalculates the multiple regression and correlation. It then removes the test with the lowest weight and so on. It also works the reverse way by starting with the best single test, that is, the one with the highest correlation with the criterion, and then successively adds tests, choosing that test among the remaining ones which makes the biggest increase in the multiple correlation. Both ways show that four tests give a multiple correlation which does not differ significantly from that obtained with all nine. This is demonstrated by the analysis of variance in Table 3 . Certain statistical difficulties have to be overcome. The usual method of calculating discriminant functions assumes that the dispersion matrices of the two groups do not differ significantly, but it has been shown that they do indeed differ (Winkel and Juhl, 1971) , the variances of the group of liver disease cases being greater than that of the controls. The method used, therefore, was to com- bine the data of the two groups and to calculate multiple correlation and regression weights. For the linear function, the weights so obtained were applied to the dispersion matrix of the control group alone in order to calculate the weights of the regression formula. Strictly speaking, a non-linear regression should have been used because of the non-homogeneity of variances. This was done, using the linear function as one variable and the squares and crossproducts of the four constituent tests as the others. This gave a multiple correlation of 0-712, which is not significantly better than the linear function. The latter is therefore adequate for the purpose. Four tests only are as effective as the full nine, and these are total bilirubin, alanine amino-transferase, zinc turbidity, and alkaline phosphatase. Their standardised weights, which show the relative importance of their contribution to the index, are respectively 0-27, 0-16, 0-29, and 0-26. They give a multiple correlation of 0 685, which is not significantly less than 0-696 obtained with all nine tests.
For the convenience of the user, the formula for the index (discriminant function) has been put into 'T-score form'. This means that the discriminant score for the control population has a mean of 50 and a standard deviation of 10. Provided that the discriminant score is normally distributed (and statistical tests show that this is true for both the control series and the series of patients) then it is known that 2-5y% of the control population can be expected to have a score of 70 points or over, 0-6 % will have a score of 75 or over, and 0-1 %Y will have a score of 80 or over. Thus a score of between 70 and 80 suggests that there may be hepatic impairment, and a score of 80 or over indicates that disturbance of function is almost certainly present. The nature of the tests indicates that the index can also be used to assess changes in function. The formula for the index is as follows: Discriminant function score = 7 65X1 + 3 36X2 + 8 33X3 + 8-19X4 or (in whole numbers) = 1/6 (Levy, 1967) . This gives 71 % and 70% correct )resenting the classification for alkaline phosphatase and total re somewhat bilirubin, respectively, down to 42% for serum c turbidity is albumin. In comparison, the linear discriminant st scores are index gives 83%. Much the same information is )tal bilirubin, obtained from examining the correlations of the ity, alkaline tests with the (dichotomous) criterion, as in Table 2 There is nothing particularly new in this investigation. Zieve and Hill (1955) constructed a discriminant function for hepatic disease 20 years ago. Why did their work not achieve wide acceptance? A partial answer to this question is that it is often the misfortune of pioneers to be premature. Perhaps the present generation of clinicians may be more sympathetic to this approach. Zieve and Hill used their discriminant function for diagnosis rather than for monitoring. They did not correct for skew dis-tributions (although they recognised their presence), which would give rise to many false positives. The tests used in this study are not the same as those used by Zieve and Hill. Although they also found that four tests were sufficient, the ones they selected were bromsulfalein, zinc turbidity, hippuric acid, and urine coproporphyrin. Clinical experience has led to the abandonment of old tests and their replacement by new ones. Even those used in this study are beginning to have an old-fashioned look about them. It is, however, of interest that the test which emerges with the highest weighting in the function is the zinc turbidity, a test which unfortunately is falling into disuse in recent years because it cannot be mechanised. Contrary to what might appear at first sight, the continued introduction of new and better tests can enhance the value of a discriminant function in the form of T-scores. As further tests come into use, they can be combined with the discriminant function, either as an addition to, or as a replacement for, the tests already included. The function becomes more efficient but its 'appearance', ie, the mean and standard deviation of controls, remains the same so that the clinician does not have to learn to interpret a new test with its own particular mean, standard deviation, and frequency distribution.
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